发明名称 MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS
摘要 The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
申请公布号 US2016326261(A1) 申请公布日期 2016.11.10
申请号 US201415105076 申请日期 2014.12.17
申请人 AIMM THERAPEUTICS B.V. 发明人 SPITS Hergen;BEAUMONT Tim;GILLISSEN Marijn Aletta;BAKKER Adrianus Quirinus;Hazenberg Mette Deborah
分类号 C07K16/30;G01N33/574;C12P21/00;A61K47/48;C07K16/40 主分类号 C07K16/30
代理机构 代理人
主权项 1. A human antibody, or a functional part or a functional equivalent thereof: wherein said human antibody or functional part or functional equivalent is isolated, synthetic or recombinant; wherein said human antibody or functional part or functional equivalent is able to bind a cell surface component of acute myeloid leukemia (AML) cells and diminish proliferation of AML cells essentially independently from antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis, or phagocytosis by macrophages or dendritic cells; wherein said human antibody or functional part or functional equivalent is coupled to another compound; and wherein said other compound is a detectable label, a chemotherapeutic drug, a toxic moiety, an immunomodulatory molecule, another AML-specific binding compound, or a radioactive compound.
地址 Amsterdam Zuidoost NL